Brittany Henderson
Endocrinology, Diabetes & Metabolism · Mount Pleasant, SCNPI 1376746453
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $120,256 of the $157,185 with a category attached, or 76.5%. 25 manufacturers reported payments, led by Amgen at 31.5% of the total. 2025 is the largest year on record at $71,908, 3.0 times the $24,328 reported in 2019. Among endocrinology, diabetes & metabolism clinicians in SC with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 441 payments — averaging $356.43 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Amgen$49K
- Madrigal Pharmaceuticals$36K
- Eisai Inc.$35K
- Ascendis Pharma Endocrinology Inc$10K
- AbbVie$10K
- IBSA Pharma Inc.$10K
- plus $7K from 19 others
Across 8 payments — averaging $9108.44 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- IBSA Pharma Inc.$73K
What the payments were for
- Consulting fees$25,02016%
- Speaking & faculty fees$120,25677%
- Travel & lodging$5,4473%
- Food & beverage$6,3934%
- Education$690%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Amgen(2 entities) | 121 | $49,441 |
| Madrigal Pharmaceuticals | 41 | $36,194 |
| Eisai Inc. | 35 | $34,537 |
| Ascendis Pharma Endocrinology Inc | 25 | $10,290 |
| AbbVie | 6 | $10,105 |
| IBSA Pharma Inc. | 62 | $9,574 |
| Arbor Pharmaceuticals, Inc. | 1 | $2,000 |
| Exelixis Inc. | 4 | $1,691 |
| Acella Pharmaceuticals, LLC | 11 | $1,330 |
| Amneal Pharmaceuticals LLC | 24 | $385 |
| Novo Nordisk | 19 | $380 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 14 | $340 |
| Kvk-tech, Inc. | 50 | $280 |
| Lilly USA, LLC | 8 | $170 |
| Boston Scientific | 1 | $102 |
| Virtus Pharmaceuticals LLC | 4 | $89 |
| Corcept Therapeutics | 3 | $52 |
| AstraZeneca | 2 | $44 |
| Ardelyx, Inc. | 2 | $44 |
| Radius Health, Inc. | 2 | $28 |
| Currax Pharmaceuticals LLC | 2 | $26 |
| Recordati_rare_diseases_inc. | 1 | $23 |
| Blueprint Medicines Corporation | 1 | $22 |
| Azurity Pharmaceuticals, Inc. | 1 | $20 |
| Bayer | 1 | $18 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$157,185 in reported general payments places this provider in the 90th percentile of 99 endocrinology, diabetes & metabolism providers in South Carolina.
See all endocrinology, diabetes & metabolism providers in South Carolina →
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| TrulicityDulaglutide | 20 | $30,977 |
| OzempicSemaglutide | 20 | $25,033 |
| MounjaroTirzepatide | 26 | $24,010 |
| TirosintLevothyroxine Sodium | 55 | $13,725 |
| Liothyronine Sodium | 107 | $9,434 |
| Armour ThyroidThyroid,pork | 54 | $6,527 |
| SynthroidLevothyroxine Sodium | 57 | $5,511 |
| ProgesteroneProgesterone, Micronized | 21 | $858 |
| Levothyroxine Sodium | 70 | $829 |
| CytomelLiothyronine Sodium | 11 | $390 |
| Metformin Hcl ErMetformin Hcl | 29 | $342 |
| LevoxylLevothyroxine Sodium | 11 | $213 |
| Methimazole | 14 | $102 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Lilly USA, LLCTrulicity, Mounjaro | $170 | $54,98646 claims |
| Novo NordiskOzempic | $380 | $25,03320 claims |
| IBSA Pharma Inc.Tirosint | $9,574 | $13,72555 claims |
| AbbVieArmour Thyroid, Synthroid | $10,105 | $12,038111 claims |
| Amneal Pharmaceuticals LLCLevothyroxine Sodium | $385 | $82970 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 99 endocrinology, diabetes & metabolism providers in South Carolina.
Other endocrinology, diabetes & metabolism in Mount Pleasant
- Gauri DhirMyrtle Beach$417K
- Cory WhiteGreenville$413K
- Louis HaenelCharleston$377K
- Vonda CalcuttWalterboro$368K
- Ray VaughtersAiken$321K
- Donald EagertonMyrtle Beach$284K
- Beatrice HullCharleston$214K
- Joseph MathewsSummerville$168K
- Zouhair BibiConway$120K
- James HortonGreenville$73K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.